Kenacort Indications/Uses

Treatment for the following conditions:
Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisones or cortisones are the drugs of choice although synthetic analogs may be used in conjunction with mineralocorticoids where applicable; mineralocorticoid supplementation is of particular importance when treating this condition in infants); congenital adrenal hyperplasia; nonsuppurative thyroiditis; and hypercalcemia associated with cancer.
Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in psoriatic arthritis; rheumatoid arthritis (selected cases may require low-dose maintenance therapy); ankylosing spondylitis; acute and subacute bursitis; acute nonspecific tenosynovitis; and acute gouty arthritis.
Collagen Diseases: For use during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus and acute rheumatic carditis.
Dermatologic Diseases: Pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, mycosis fungoides and severe psoriasis.
Allergic States: For the control of seasonal or perennial allergic rhinitis, bronchial asthma, contact dermatitis, atopic dermatitis, serum sickness, angioedema and urticaria when they are severe or incapacitating and intractable to adequate trials of conventional treatment.
Ophthalmic Diseases: Severe, acute and chronic allergic and inflammatory processes involving the eye and its associated anatomic parts eg, allergic conjunctivitis, keratitis, allergic corneal marginal ulcers, herpes zoster ophthalmicus, iritis and iridocyclitis, chorioretinitis, anterior segment inflammation, diffuse posterior uveitis and choroiditis, optic neuritis and sympathetic ophthalmia.
Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis when concurrently accompanied by appropriate antituberculous chemotherapy, pulmonary emphysema where bronchospasm or bronchial edema plays a significant role and diffuse interstitial pulmonary fibrosis (Hamman-Rich syndrome).
Hematologic Disorders: Idiopathic and secondary thrombocytopenia in adults, acquired (auto-immune) hemolytic anemia, erythroblastopenia (RBC anemia) and congenital (erythroid) hypoplastic anemia.
Neoplastic Diseases: For palliative management of leukemias and lymphomas in adults and acute leukemia in childhood.
Edematous States: To induce diuresis or remission of proteinuria in the nephrotic syndrome (non-uremic, the idiopathic type or that which is due to lupus erythematosus) and, in conjunction with diuretic agents, to induce diuresis in refractory congestive heart failure and in cirrhosis of the liver with refractory ascites.
Gastrointestinal Diseases: To tide the patient over a critical period of the disease in ulcerative colitis, regional enteritis and intractable sprue.
Miscellaneous: Dental postoperative inflammatory reactions and tuberculous meningitis with subarachnoid block or impending block when concurrently accompanied by appropriate antituberculous chemotherapy.